ArticleFrontiers in immunology2022

Identification of OTUD6B as a new biomarker for prognosis and immunotherapy by pan-cancer analysis.

Guang Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.